MQS Management’s Gilead Sciences GILD Stock Holding History

MQS Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$387K	Buy	+3,065	New	+$404K	0.47%	70
2026 Q1	–	Sell	-3,189	Closed	-$391K	–	470
2025 Q4	$391K	Sell	3,189 -108	-3%	-$13.1K	0.23%	176
2025 Q3	$366K	Buy	+3,297	New	+$375K	0.21%	195
2024 Q3	–	Sell	-4,573	Closed	-$314K	–	525
2024 Q2	$314K	Buy	4,573 +1,157	+34%	+$77.2K	0.19%	230
2024 Q1	$250K	Buy	+3,416	New	+$263K	0.14%	314
2023 Q4	–	Sell	-5,918	Closed	-$443K	–	537
2023 Q3	$443K	Buy	5,918 +2,185	+59%	+$168K	0.27%	141
2023 Q2	$288K	Buy	+3,733	New	+$298K	0.2%	234
2022 Q3	–	Sell	-4,080	Closed	-$252K	–	483
2022 Q2	$252K	Sell	4,080 -5,266	-56%	-$326K	0.17%	260
2022 Q1	$556K	Buy	+9,346	New	+$597K	0.45%	49

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

MQS Management's GILD Position: Q2 2026 in Review

MQS Management opened a new position in Gilead Sciences (GILD) in Q2 2026: 3,065 shares worth $387K. The stake represents 0.47% of the portfolio and ranks #70 among its holdings. This is a return to the name: MQS Management previously reported a position in GILD as recently as Q4 2025.

MQS Management first reported a position in GILD in Q1 2022 and has held it in 9 quarters since. The position peaked at $556K in Q1 2022. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

MQS Management held 3,065 shares of Gilead Sciences worth $387K as of Q2 2026.
Gilead Sciences was a new MQS Management position in Q2 2026.
Gilead Sciences made up 0.47% of MQS Management's portfolio in Q2 2026, its #70 holding.
MQS Management first reported a position in Gilead Sciences in Q1 2022 and has held it in 9 quarters since.
MQS Management's Gilead Sciences position peaked at $556K in Q1 2022.
2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on MQS Management's 13F filing for Q2 2026, filed 7 Aug 2026.